Day Range105.320 - 107.515 | 52 Wk Range72.875 - 115.490 | Open / Close105.810 / 106.640 | Float / Outstanding2.534B / 2.535B |
Vol / Avg.8.596M / 9.165M | Mkt Cap270.400B | P/E18.676 | 50d Avg. Price109.500 |
Div / Yield (Forward)2.800 / 2.74% | Payout Ratio0.490 | Total Float2.534B | EPS5.730 |
Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Day Range105.320 - 107.515 | 52 Wk Range72.875 - 115.490 | Open / Close105.810 / 106.640 | Float / Outstanding2.534B / 2.535B |
Vol / Avg.8.596M / 9.165M | Mkt Cap270.400B | P/E18.676 | 50d Avg. Price109.500 |
Div / Yield (Forward)2.800 / 2.74% | Payout Ratio0.490 | Total Float2.534B | EPS5.730 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-04-27 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.540 | 1.620 | 0.0800 | ||||
REV | 13.670B | 13.830B | 160.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Merck & Co (NYSE: MRK) was reported by Wells Fargo on Friday, February 3, 2023. The analyst firm set a price target for 120.00 expecting MRK to rise to within 12 months (a possible 12.52% upside). 38 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $106.65 last updated February 8, 2023 at 8:59 PM UTC.
The next Merck & Co (MRK) dividend date is projected to be Tuesday, March 14, 2023.
Merck & Co’s Q1 earnings are confirmed for Thursday, April 27, 2023.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Day Range105.320 - 107.515 | 52 Wk Range72.875 - 115.490 | Open / Close105.810 / 106.640 | Float / Outstanding2.534B / 2.535B |
Vol / Avg.8.596M / 9.165M | Mkt Cap270.400B | P/E18.676 | 50d Avg. Price109.500 |
Div / Yield (Forward)2.800 / 2.74% | Payout Ratio0.490 | Total Float2.534B | EPS5.730 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-04-27 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.540 | 1.620 | 0.0800 | ||||
REV | 13.670B | 13.830B | 160.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Merck & Co (NYSE: MRK) was reported by Wells Fargo on Friday, February 3, 2023. The analyst firm set a price target for 120.00 expecting MRK to rise to within 12 months (a possible 12.52% upside). 38 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $106.65 last updated February 8, 2023 at 8:59 PM UTC.
The next Merck & Co (MRK) dividend date is projected to be Tuesday, March 14, 2023.
Merck & Co’s Q1 earnings are confirmed for Thursday, April 27, 2023.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Day Range105.320 - 107.515 | 52 Wk Range72.875 - 115.490 | Open / Close105.810 / 106.640 | Float / Outstanding2.534B / 2.535B |
Vol / Avg.8.596M / 9.165M | Mkt Cap270.400B | P/E18.676 | 50d Avg. Price109.500 |
Div / Yield (Forward)2.800 / 2.74% | Payout Ratio0.490 | Total Float2.534B | EPS5.730 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-04-27 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.540 | 1.620 | 0.0800 | ||||
REV | 13.670B | 13.830B | 160.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Merck & Co (NYSE: MRK) was reported by Wells Fargo on Friday, February 3, 2023. The analyst firm set a price target for 120.00 expecting MRK to rise to within 12 months (a possible 12.52% upside). 38 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $106.65 last updated February 8, 2023 at 8:59 PM UTC.
The next Merck & Co (MRK) dividend date is projected to be Tuesday, March 14, 2023.
Merck & Co’s Q1 earnings are confirmed for Thursday, April 27, 2023.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Day Range105.320 - 107.515 | 52 Wk Range72.875 - 115.490 | Open / Close105.810 / 106.640 | Float / Outstanding2.534B / 2.535B |
Vol / Avg.8.596M / 9.165M | Mkt Cap270.400B | P/E18.676 | 50d Avg. Price109.500 |
Div / Yield (Forward)2.800 / 2.74% | Payout Ratio0.490 | Total Float2.534B | EPS5.730 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-04-27 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.540 | 1.620 | 0.0800 | ||||
REV | 13.670B | 13.830B | 160.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Merck & Co (NYSE: MRK) was reported by Wells Fargo on Friday, February 3, 2023. The analyst firm set a price target for 120.00 expecting MRK to rise to within 12 months (a possible 12.52% upside). 38 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $106.65 last updated February 8, 2023 at 8:59 PM UTC.
The next Merck & Co (MRK) dividend date is projected to be Tuesday, March 14, 2023.
Merck & Co’s Q1 earnings are confirmed for Thursday, April 27, 2023.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Day Range105.320 - 107.515 | 52 Wk Range72.875 - 115.490 | Open / Close105.810 / 106.640 | Float / Outstanding2.534B / 2.535B |
Vol / Avg.8.596M / 9.165M | Mkt Cap270.400B | P/E18.676 | 50d Avg. Price109.500 |
Div / Yield (Forward)2.800 / 2.74% | Payout Ratio0.490 | Total Float2.534B | EPS5.730 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-04-27 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.540 | 1.620 | 0.0800 | ||||
REV | 13.670B | 13.830B | 160.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Merck & Co (NYSE: MRK) was reported by Wells Fargo on Friday, February 3, 2023. The analyst firm set a price target for 120.00 expecting MRK to rise to within 12 months (a possible 12.52% upside). 38 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $106.65 last updated February 8, 2023 at 8:59 PM UTC.
The next Merck & Co (MRK) dividend date is projected to be Tuesday, March 14, 2023.
Merck & Co’s Q1 earnings are confirmed for Thursday, April 27, 2023.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Day Range105.320 - 107.515 | 52 Wk Range72.875 - 115.490 | Open / Close105.810 / 106.640 | Float / Outstanding2.534B / 2.535B |
Vol / Avg.8.596M / 9.165M | Mkt Cap270.400B | P/E18.676 | 50d Avg. Price109.500 |
Div / Yield (Forward)2.800 / 2.74% | Payout Ratio0.490 | Total Float2.534B | EPS5.730 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-04-27 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.540 | 1.620 | 0.0800 | ||||
REV | 13.670B | 13.830B | 160.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Merck & Co (NYSE: MRK) was reported by Wells Fargo on Friday, February 3, 2023. The analyst firm set a price target for 120.00 expecting MRK to rise to within 12 months (a possible 12.52% upside). 38 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $106.65 last updated February 8, 2023 at 8:59 PM UTC.
The next Merck & Co (MRK) dividend date is projected to be Tuesday, March 14, 2023.
Merck & Co’s Q1 earnings are confirmed for Thursday, April 27, 2023.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Day Range105.320 - 107.515 | 52 Wk Range72.875 - 115.490 | Open / Close105.810 / 106.640 | Float / Outstanding2.534B / 2.535B |
Vol / Avg.8.596M / 9.165M | Mkt Cap270.400B | P/E18.676 | 50d Avg. Price109.500 |
Div / Yield (Forward)2.800 / 2.74% | Payout Ratio0.490 | Total Float2.534B | EPS5.730 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-04-27 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.540 | 1.620 | 0.0800 | ||||
REV | 13.670B | 13.830B | 160.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Merck & Co (NYSE: MRK) was reported by Wells Fargo on Friday, February 3, 2023. The analyst firm set a price target for 120.00 expecting MRK to rise to within 12 months (a possible 12.52% upside). 38 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $106.65 last updated February 8, 2023 at 8:59 PM UTC.
The next Merck & Co (MRK) dividend date is projected to be Tuesday, March 14, 2023.
Merck & Co’s Q1 earnings are confirmed for Thursday, April 27, 2023.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Day Range105.320 - 107.515 | 52 Wk Range72.875 - 115.490 | Open / Close105.810 / 106.640 | Float / Outstanding2.534B / 2.535B |
Vol / Avg.8.596M / 9.165M | Mkt Cap270.400B | P/E18.676 | 50d Avg. Price109.500 |
Div / Yield (Forward)2.800 / 2.74% | Payout Ratio0.490 | Total Float2.534B | EPS5.730 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-04-27 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.540 | 1.620 | 0.0800 | ||||
REV | 13.670B | 13.830B | 160.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Merck & Co (NYSE: MRK) was reported by Wells Fargo on Friday, February 3, 2023. The analyst firm set a price target for 120.00 expecting MRK to rise to within 12 months (a possible 12.52% upside). 38 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $106.65 last updated February 8, 2023 at 8:59 PM UTC.
The next Merck & Co (MRK) dividend date is projected to be Tuesday, March 14, 2023.
Merck & Co’s Q1 earnings are confirmed for Thursday, April 27, 2023.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Day Range105.320 - 107.515 | 52 Wk Range72.875 - 115.490 | Open / Close105.810 / 106.640 | Float / Outstanding2.534B / 2.535B |
Vol / Avg.8.596M / 9.165M | Mkt Cap270.400B | P/E18.676 | 50d Avg. Price109.500 |
Div / Yield (Forward)2.800 / 2.74% | Payout Ratio0.490 | Total Float2.534B | EPS5.730 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-04-27 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.540 | 1.620 | 0.0800 | ||||
REV | 13.670B | 13.830B | 160.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Merck & Co (NYSE: MRK) was reported by Wells Fargo on Friday, February 3, 2023. The analyst firm set a price target for 120.00 expecting MRK to rise to within 12 months (a possible 12.52% upside). 38 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $106.65 last updated February 8, 2023 at 8:59 PM UTC.
The next Merck & Co (MRK) dividend date is projected to be Tuesday, March 14, 2023.
Merck & Co’s Q1 earnings are confirmed for Thursday, April 27, 2023.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.